tiprankstipranks
David Drutz to Exit Altimmune Board at Next Annual Meeting
Company Announcements

David Drutz to Exit Altimmune Board at Next Annual Meeting

Pick the best stocks and maximize your portfolio:

Altimmune (ALT) just unveiled an announcement.

David J. Drutz, M.D. has announced he will not seek re-election to the Board of Directors for Altimmune, Inc. at the upcoming 2024 Annual Meeting of Shareholders, although he will serve until then. His departure is not related to any operational, policy, or practice disagreements with the Company, and the Board has expressed gratitude for his contributions during his tenure.

See more insights into ALT stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAltimmune call volume above normal and directionally bullish
TheFlyLargest borrow rate increases among liquid names
TheFlyAltimmune to be added to the Nasdaq Biotechnology Index
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App